OTTAWA (CP) - PharmaGap Inc. has appointed former Ottawa Senators owner Rod Bryden as the cancer drug developer's new chairman.
Ottawa-based PharmaGap (TSXV:GAP) said Thursday that Bryden will replace Dan Larkin, who remains a member of the company's board of directors....More
Posts
No comments:
Post a Comment